Clinical and Experimental Metastasis

短名Clin Exp Metastasis
Journal Impact4.19
国际分区ONCOLOGY(Q2)
期刊索引SCI Q2中科院 3 区
ISSN0262-0898, 1573-7276
h-index109
国内分区医学(3区)医学肿瘤学(3区)

该杂志的范围涵盖了转移研究的所有方面,无论是基于实验室的、实验性的还是临床和治疗的。它涵盖分子生物学、药理学、肿瘤生物学和临床癌症治疗等领域(包括手术、化学疗法和放射治疗以及病理学和流行病学),只要这些学科与该杂志的核心主题转移形成、预防和治疗有关。

期刊主页投稿网址
涉及主题医学生物内科学遗传学化学癌症生物化学癌症研究病理免疫学外科转移肿瘤科外科肿瘤学基因细胞生物学细胞培养细胞体外心理学物理精神科内分泌学有机化学
出版信息出版商: Springer Science and Business Media B.V.出版周期: Bimonthly期刊类型: journal
基本数据创刊年份: 1983原创研究文献占比73.47%自引率:2.40%Gold OA占比: 38.89%
平均审稿周期 网友分享经验:平均12月
平均录用比例网友分享经验:约25%

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model

2024-9-5

Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis

2024-9-4

Cell blebbing novel therapeutic possibilities to counter metastasis

2024-9-2

Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis

2024-8-31

Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics

2024-8-20

Immune responses and immunotherapeutic approaches in the treatment against cancer

2024-8-18

Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model

2024-8-10

Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)

2024-8-1

Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells

2024-7-27

Correction: SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells

2024-7-27

Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations

2024-7-17

Cancer metastasis through the lymphatic versus blood vessels

2024-6-28

UBTF mediates activation of L3MBTL2 to suppress NISCH expression through histone H2AK119 monoubiquitination modification in breast cancer

2024-6-27

Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches

2024-6-27

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2

2024-6-22

GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthetic pathway in pancreatic cancer

2024-6-18

Correction: Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma

2024-6-10

Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project

2024-6-8

Membrane Lipid Replacement for reconstituting mitochondrial function and moderating cancer-related fatigue, pain and other symptoms while counteracting the adverse effects of cancer cytotoxic therapy

2024-6-1

SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells

2024-5-26

Correction to: Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis

2024-5-22

A clinical-radiomics nomogram based on spectral CT multi-parameter images for preoperative prediction of lymph node metastasis in colorectal cancer

2024-5-20

Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis

2024-5-18

A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer

2024-5-8

Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors

2024-4-29

Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma

2024-4-13

Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer

2024-4-12

Stress-induced phosphoprotein 1: how does this co-chaperone influence the metastasis steps?

2024-4-6

Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis

2024-4-6

Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma

2024-4-3

Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases

2024-3-29

Forty years on: a brief history of clinical and experimental metastasis

2024-3-23

How much do we know about the metastatic process?

2024-3-23

TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer

2024-3-18

The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria

2024-3-15

Current pharmacologic treatment of brain metastasis in non-small cell lung cancer

2024-3-11

From pre-clinical to translational brain metastasis research: current challenges and emerging opportunities

2024-3-2

Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma

2024-2-29

Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis

2024-2-28

Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer

2024-2-28

Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics

2024-2-28

CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling

2024-2-24

Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model

2024-2-17

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

2024-2-16

Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models

2024-2-14

Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection

2024-2-14

Interrogating the roles of lymph node metastasis in systemic immune surveillance

2024-2-5

Neoadjuvant therapy for resectable melanoma

2024-1-28

Clinical applications of circulating tumor cells in patients with solid tumors

2024-1-28

Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade

2024-1-23

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司